Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

This review describes the preclinical mechanisms that may underlie the increased therapeutic benefit of combination therapy—with the N-methyl-d-aspartate receptor antagonist, memantine, and an acetylcholinesterase inhibitor (AChEI)—for the treatment of Alzheimer’s disease (AD). Memantine, and the AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Chris G., Danysz, Wojciech, Dekundy, Andrzej, Pulte, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753463/
https://www.ncbi.nlm.nih.gov/pubmed/23657927
http://dx.doi.org/10.1007/s12640-013-9398-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753463/
https://www.ncbi.nlm.nih.gov/pubmed/23657927
http://dx.doi.org/10.1007/s12640-013-9398-z

Ejemplares similares